Literature DB >> 3370535

Myosin light chain phosphorylation and contractile performance of human skeletal muscle.

D S Stuart1, M D Lingley, R W Grange, M E Houston.   

Abstract

Twitch tension and maximal unloaded velocity of human knee extensor muscles were studied under conditions of low phosphate content of the phosphorylatable light chains (P-light chains) of myosin and elevated phosphate content, following a 10-s maximal voluntary isometric contraction (MVC). After the MVC, twitch tension was significantly potentiated, with greater potentiation observed at a shorter muscle length (p less than 0.05). The MVC was associated with at least a twofold increase in phosphate content of the fast (LC2F) and two slow (LC2S and LC2S') P-light chains, but this increase was unrelated to muscle length. No significant differences in knee extension velocity were observed between conditions where P-light chains had low or elevated phosphate content. Positive but nonsignificant correlations were noted between the extent of twitch potentiation and phosphate content of individual P-light chains as well as the percentage of type II muscle fibres in vastus lateralis muscle. No significant relationships were determined for myosin light chain kinase activity and either P-light chain phosphorylation or type II fibre percentage. These data suggest that, unlike other mammalian fast muscles, P-light chain phosphorylation of mixed human muscles is not strongly associated with altered contractile performance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370535     DOI: 10.1139/y88-009

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  9 in total

1.  Musculoskeletal adaptations in chronic spinal cord injury: effects of long-term soleus electrical stimulation training.

Authors:  Richard K Shields; Shauna Dudley-Javoroski
Journal:  Neurorehabil Neural Repair       Date:  2007 Mar-Apr       Impact factor: 3.919

Review 2.  Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle.

Authors:  James T Stull; Kristine E Kamm; Rene Vandenboom
Journal:  Arch Biochem Biophys       Date:  2011-02-01       Impact factor: 4.013

Review 3.  Factors modulating post-activation potentiation and its effect on performance of subsequent explosive activities.

Authors:  Neale Anthony Tillin; David Bishop
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

4.  Postactivation potentiation of short tetanic contractions is differently influenced by stimulation frequency in young and elderly adults.

Authors:  Stéphane Baudry; Malgorzata Klass; Jacques Duchateau
Journal:  Eur J Appl Physiol       Date:  2008-07       Impact factor: 3.078

5.  Myosin light chain phosphorylation and posttetanic potentiation in fatigued skeletal muscle.

Authors:  L A Tubman; B R MacIntosh; W A Maki
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

6.  Influence of fascicle length on twitch potentiation of the medial gastrocnemius across three ankle angles.

Authors:  Samantha L Kuzyk; Rowan R Smart; Carey L Simpson; Andrey Fedorov; Jennifer M Jakobi
Journal:  Eur J Appl Physiol       Date:  2018-03-30       Impact factor: 3.078

7.  Measured and modeled properties of mammalian skeletal muscle. I. The effects of post-activation potentiation on the time course and velocity dependencies of force production.

Authors:  I E Brown; G E Loeb
Journal:  J Muscle Res Cell Motil       Date:  1999-08       Impact factor: 2.698

8.  Myosin light chain phosphorylation during staircase in fatigued skeletal muscle.

Authors:  B R MacIntosh; R W Grange; C R Cory; M E Houston
Journal:  Pflugers Arch       Date:  1993-10       Impact factor: 3.657

9.  Do Thirty-Second Post-activation Potentiation Exercises Improve the 50-m Freestyle Sprint Performance in Adolescent Swimmers?

Authors:  Zied Abbes; Karim Chamari; Iñigo Mujika; Montassar Tabben; Khalid W Bibi; Ali Mostafa Hussein; Cyril Martin; Monoem Haddad
Journal:  Front Physiol       Date:  2018-10-22       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.